Marker Therapeutics Inc (MRKR)

[AntiMarv]

The $200 million shelf telegraphs the pancreatic results are going to be great. IMO we would have just gone about our AML phase I and not raised money until early next year. The $200 million implies to me the share price is going up significantly so our dilution will be minimal . I believe the stock will be halted on July 22nd or July 23 after the ceo speaks. I expect either a partnership with big pharma on pancreatic cancer or so word on the next steps with the fda for approval. As far as shorting, I am set up at fidelity to do it but only did it on 6 shares of Tesla. The fake meat company has a 99% interest rate right now . So I believe the rate for fidelity will approach that unless the shorts cover.